Revolutionary Advances in Rheumatology: CAR-T and Precision Medicine Insight from Tiffany

In this update from EULAR 2024, we explore groundbreaking advancements in precision medicine and their potential to transform rheumatology. Discover how CAR-T therapy, a treatment previously successful in cancer, is now showing remarkable promise for severe autoimmune diseases like lupus and scleroderma. Learn about the science behind precision medicine, its potential to expedite diagnosis and personalize treatment, and the exciting prospects for achieving remission. Don't miss this insightful dive into the future of rheumatology!
00:00 Introduction to sessions
00:46 CAR-T therapy, new advancement in rheumatology
01:26 Studies where patients went into total remission
03:18 Who will get this treatment? What diseases?
04:14 Diseases with less options: when do you start to treat?
04:58 Treat to target process (T2T), early intervention
05:30 Precision Medicine; subgroup responses
06:46 Predictive markers
07:27 CAR-T in Scleroderma
08:57 Conclusion